Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, Par Value $0.001
-
Shares outstanding
-
94.7M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
74.8M
-
Shares change
-
+751K
-
Total reported value, excl. options
-
$723M
-
Value change
-
+$4.59M
-
Number of buys
-
49
-
Number of sells
-
-22
-
Price
-
$9.67
Significant Holders of Enfusion Inc. - Common Stock, Par Value $0.001 (ENFN) as of Q4 2022
84 filings reported holding ENFN - Enfusion Inc. - Common Stock, Par Value $0.001 as of Q4 2022.
Enfusion Inc. - Common Stock, Par Value $0.001 (ENFN) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.8M shares
of 94.7M outstanding shares and own 78.99% of the company stock.
Largest 10 shareholders include FTV Management Company, L.P. (31.3M shares), ICONIQ Capital, LLC (14M shares), Dragoneer Investment Group, LLC (6.03M shares), BROWN CAPITAL MANAGEMENT LLC (6M shares), HHLR ADVISORS, LTD. (4.98M shares), Ararat Capital Management, LP (2.33M shares), VANGUARD GROUP INC (2.19M shares), BlackRock Inc. (1.63M shares), JANUS HENDERSON GROUP PLC (1.34M shares), and ALLIANCEBERNSTEIN L.P. (1.09M shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.